Physician profile
Jack W Griffith
NPI 1407884315
$5,177.94
in general payments reported to CMS, 2019-2025
19 companies · $891 in 2025
The $891 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $684 · 2020: $174 · 2021: $508 · 2022: $933 · 2023: $938 · 2024: $1,049 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,538 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.95 |
| Education | $339.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,404.66 | 2019-2025 | |
| Abbvie INC. | $823.07 | 2019-2025 | |
| Ucb, INC. | $526.52 | 2019-2024 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $384.03 | 2021-2024 | Ilumya |
| Janssen Biotech, INC. | $373.89 | 2022-2024 | Tremfya |
| Galderma Laboratories, L.P. | $338.80 | 2019-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $292.85 | 2021-2025 | Dupixent |
| Incyte Corporation | $233.69 | 2022-2025 | Opzelura |
| Genentech USA, INC. | $201.70 | 2019-2022 | |
| Organon LLC | $150.87 | 2025 | Vtama |
| Sanofi-Aventis U.S. LLC | $135.45 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $106.40 | 2019-2025 | |
| Pfizer INC. | $81.32 | 2019-2025 | |
| Amgen INC. | $40.51 | 2023-2025 | Otezla |
| Biofrontera INC. | $23.06 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $21.70 | 2022 | |
| Leo Pharma INC. | $16.00 | 2024 | Adbry |
| Vyne Pharmaceuticals INC. | $11.72 | 2021 | |
| Mayne Pharma Commercial LLC | $11.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.